Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment of COVID-19
4 years ago
It is our honor to bring Dr. McCullough back to "Doctors Are In" to discuss the latest on reducing COVID-19 hospitalization and death with early treatment with an in depth overview and update on ambulatory treatment studies and the new sequenced, multi-drug therapeutic regimen for high-risk COVID-19 patients. https://rcm.imrpress.com/article/2020/2153-8174/RCM2020264.shtml
Loading comments...
-
17:31
Association of American Physicians and Surgeons
1 month agoCompounded Amlexanox: A Novel Approach In a World Full of Metabolic Disease
245 -
4:46
WMAR
5 years agoCOVID-19 Early Treatment Fund
1.16K -
2:33
KGTV
4 years agoSupercomputer simulates COVID-19 treatment
1691 -
0:20
WFTX
4 years agoNew COVID-19 vaccine clinical trial
243 -
2:11
WCPO
4 years agoStudy: Concerns surrounding COVID-19 treatment Remdesivir
6443 -
0:43
KMGH
4 years agoUCHealth testing Bimlanivimab - Covid-19 antibody treatment
91 -
2:05
KGTV
5 years agoPresident Trump's COVID-19 antibody treatment
1.59K1 -
2:38
KJRH
4 years agoMonoclonal antibodies treatment used in high-risk COVID-19 patients
524 -
0:32
KTNV
4 years agoCOVID-19 antibody treatment being used in Las Vegas
167 -
0:24
Newsy
4 years agoFDA Approves Emergency COVID-19 Antibody Treatment
1.15K